Michael Bavaro - 10 Mar 2023 Form 4 Insider Report for Option Care Health, Inc. (OPCH)

Role
Chief Human Resources Officer
Signature
/s/ Sarah Kim, attorney-in-fact for Mr. Bavaro
Issuer symbol
OPCH
Transactions as of
10 Mar 2023
Net transactions value
-$95,227
Form type
4
Filing time
14 Mar 2023, 18:46:15 UTC
Previous filing
24 Feb 2023
Next filing
21 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPCH Common Stock Options Exercise $51,586 +2,153 +9.3% $23.96 25,245 10 Mar 2023 Direct
transaction OPCH Common Stock Options Exercise $46,514 +2,452 +9.7% $18.97 27,697 10 Mar 2023 Direct
transaction OPCH Common Stock Sale $193,327 -6,148 -22% $31.45 21,549 10 Mar 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OPCH Employee Stock Option (right to buy) Options Exercise $0 -2,153 -25% $0.000000 6,459 10 Mar 2023 Common Stock 2,153 $23.96 Direct F2
transaction OPCH Employee Stock Option (right to buy) Options Exercise $0 -2,452 -50% $0.000000 2,452 10 Mar 2023 Common Stock 2,452 $18.97 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the weighted average price of 6,148 shares of common stock of Option Care Health, Inc. sold by the reporting person in multiple transactions on March 10, 2023 with sale prices ranging from $31.44 to $31.46 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F2 Stock options that vest as to 25% of the underlying shares of Common Stock on each of February 17, 2023, February 17, 2024, February 17, 2025 and February 17, 2026.
F3 Stock options that vest as to 50% of the underlying shares of Common Stock on February 23, 2023, and 25% of the underlying shares of Common Stock on each of February 23, 2024 and February 23, 2025.